Our previous study showed that CKII could phosphorylate the C-terminus of NIP30 (36), indicating that fine-tuning the NIP30/REGγ/TRAF6 axis is a potential strategy to treat osteoporosis. This evidence concerns the gene TRAF6 and osteoporosis.